Organovo (ONVO) Projected to Post Quarterly Earnings on Thursday

Organovo (NASDAQ:ONVO) is expected to issue its quarterly earnings data before the market opens on Thursday, February 13th. Analysts expect the company to announce earnings of ($0.21) per share and revenue of $0.05 million for the quarter.

Organovo (NASDAQ:ONVO) last released its earnings results on Friday, November 8th. The medical research company reported ($0.14) earnings per share for the quarter, beating analysts’ consensus estimates of ($0.26) by $0.12. The firm had revenue of $0.03 million for the quarter, compared to analysts’ expectations of $0.04 million. Organovo had a negative net margin of 12,176.70% and a negative return on equity of 249.28%. On average, analysts expect Organovo to post $-1 EPS for the current fiscal year and $-1 EPS for the next fiscal year.

Organovo Trading Down 0.8 %

NASDAQ:ONVO opened at $0.35 on Tuesday. The firm’s 50 day moving average is $0.39 and its 200 day moving average is $0.46. Organovo has a 12 month low of $0.32 and a 12 month high of $1.74. The stock has a market capitalization of $5.33 million, a PE ratio of -0.33 and a beta of 0.54.

Wall Street Analysts Forecast Growth

Separately, StockNews.com assumed coverage on shares of Organovo in a report on Friday. They set a “sell” rating on the stock.

Organovo Company Profile

Organovo Holdings, Inc, a biotechnology company, focuses on developing 3D tissues that recapitulate key aspects of human disease. Its 3D human tissue platform includes its proprietary NovoGen Bioprinters, which are automated devices that enable the fabrication of 3D living tissues comprised mammalian cells; and related technologies for preparing bio-inks and bioprinting multicellular tissues with complex architecture.